1. Home
  2. MTRX vs AUTL Comparison

MTRX vs AUTL Comparison

Compare MTRX & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$13.16

Market Cap

342.7M

ML Signal

HOLD

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.87

Market Cap

407.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
AUTL
Founded
1984
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
342.7M
407.2M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
MTRX
AUTL
Price
$13.16
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$17.00
$8.50
AVG Volume (30 Days)
272.9K
1.6M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$769,286,000.00
$10,120,000.00
Revenue This Year
$19.75
$80.32
Revenue Next Year
$7.96
$53.96
P/E Ratio
N/A
N/A
Revenue Growth
5.64
496.00
52 Week Low
$9.88
$1.18
52 Week High
$16.11
$2.70

Technical Indicators

Market Signals
Indicator
MTRX
AUTL
Relative Strength Index (RSI) 57.94 64.77
Support Level $11.93 $1.27
Resistance Level $13.44 $1.98
Average True Range (ATR) 0.45 0.13
MACD 0.06 0.02
Stochastic Oscillator 89.59 86.54

Price Performance

Historical Comparison
MTRX
AUTL

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: